MHC
AMGN icon

May Hill Capital’s Amgen AMGN Stock Holding History

May Hill Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Sell
1,092
-27
-2% -$9.24K 0.08% 154
2026
Q1 		$394K Buy
1,119
+196
+21% +$69.9K 0.1% 137
2025
Q4 		$302K Buy
923
+17
+2% +$5.39K 0.08% 148
2025
Q3 		$256K Sell
906
-23
-2% -$6.67K 0.08% 160
2025
Q2 		$259K Sell
929
-388
-29% -$110K 0.09% 155
2025
Q1 		$410K Buy
1,317
+62
+5% +$18.3K 0.15% 98
2024
Q4 		$327K Buy
+1,255
New +$372K 0.13% 107

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

May Hill Capital's AMGN Position: Q2 2026 in Review

May Hill Capital reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $9.24K and leaving 1,092 shares worth $396K. The position accounts for 0.08% of the portfolio, ranked #154.

May Hill Capital first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $410K in Q1 2025. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • May Hill Capital held 1,092 shares of Amgen worth $396K as of Q2 2026.
  • May Hill Capital sold 27 Amgen shares in Q2 2026, an estimated $9.24K.
  • Amgen made up 0.08% of May Hill Capital's portfolio in Q2 2026, its #154 holding.
  • May Hill Capital first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • May Hill Capital's Amgen position peaked at $410K in Q1 2025.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.